↓ Skip to main content

Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients

Overview of attention for article published in Frontiers in oncology, October 2023
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
1 Mendeley